Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome.
Valion Bio stock last closed at $2.12, down 4.93% from the previous day, and has decreased 97.29% in one year. It has underperformed other stocks in the Biotechnology industry by 0.75 percentage points. Valion Bio stock is currently +3.41% from its 52-week low of $2.05, and -97.31% from its 52-week high of $78.75.
At the moment, there are 887,590 shares of VBIO outstanding. The market value of VBIO is $1.88M. In the last 24 hours, 57,000 VBIO shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy VBIO shares.
Based on our analysis, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal information so you can buy VBIO stock today.
Now that you have filled out your info on a good stock buying app, you need to deposit funds:
Watch the video below for more details transferring money into your investment account.
Once you have selected the best place to buy Valion Bio stock, it's critical to research their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on VBIO's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge VBIO's intrinsic value.
Using relative valuations measures:
You can do additional valuation analysis on VBIO's stock here.
Over the past year, executives and large shareholders at VBIO have bought more shares than they have sold.
Sheryle Bolton, Director of VBIO, was the latest VBIO insider to buy. They bought $10,400.00 worth of VBIO shares on Apr 15, 2026.
Learn more about who owns VBIO shares here.
No, Valion Bio doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary order types:
Press the Open Trade button and your broker will place the order.
If you want additional help buying stocks on eToro, watch the how to video below:
Now that you own some VBIO shares, you'll want to stay up-to-date on your shares.
Make a watchlist to get the latest updates about your VBIO stock.
To summarize, here are the 6 steps you need to take to buy Valion Bio stock right now:
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Valion Bio, click below.